Michał Wasiak
Medical University of Silesia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michał Wasiak.
Cardiology Journal | 2012
Łukasz J. Krzych; Krystyna Bochenek-Klimczyk; Michał Wasiak; Krzysztof Białek; Maciej Bolkowski; Danuta Gierek; Andrzej Bochenek
Surgical revascularization with coronary artery by-pass grafting is still recommended in vast majority of patients with unprotected left main disease. The aim of the paper was to analyze optimal treatment of left main disease in selected groups of patients, on the basis of current guidelines and information gained from literature data. We focused on data in relation to treatment of elderly patients, diabetics and those hemodynamically unstable. Additionally we discussed the issue of anti-platelet therapy and informed consent. As far as efficacy of treatment is concerned, not only method of revascularization but also general condition of the patient, the factors influencing peri-operative risk and optimal pharmacotherapy should be taken into account. Therefore establishment of the heart team is crucial when choosing the most suitable method of invasive treatment of left main disease.
Journal of Cardiovascular Electrophysiology | 2017
Anna Kurek; Mateusz Tajstra; Elzbieta Gadula-Gacek; Piotr Buchta; Michał Skrzypek; Lukasz Pyka; Michał Wasiak; Malgorzata Swietlinska; Michał Hawranek; Lech Poloński; Mariusz Gasior; F.E.S.C. Jedrzej Kosiuk M.D.
Randomized controlled trials demonstrate that remote monitoring (RM) of implantable cardioverter–defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT‐Ds) may improve quality of care and prognosis in heart failure (HF) patients. However, the impact of RM on long‐term mortality in a real‐world cohort is still not well examined.
Cardiology Journal | 2013
Jarosław Wasilewski; Łukasz Pyka; Michał Hawranek; Mateusz Tajstra; Michał Skrzypek; Michał Wasiak; Kamil Suliga; Kamil Bujak; Mariusz Gąsior
BACKGROUND Previous studies have reported that in patients with heart failure, an increased value of red cell distribution width (RDW) is associated with adverse outcomes. Nonetheless, data regarding the association between RDW values and long-term mortality in patients with left ventricular systolic dysfunction (LVSD) are lacking. The aim of this investigation was to examine the relationship between mortality and RDW in patients with ischemic and non-ischemic LVSD. METHODS Under analysis was 1734 patients with a left ventricular ejection fraction (LVEF) ≤ 35% of whom were hospitalized between 2009 and 2013. Patients were divided into three groups based on RDW tertiles. Low, medium and high tertiles were defined as RDW ≤ 13.4%, 13.4% < RDW ≤ 14.6% and RDW > 14.6%, respectively. RESULTS There was a stepwise relationship between RDW intervals and comorbidities. Patients with the highest RDW values were older and more often diagnosed with anemia, diabetes, atrial fibrillation and chronic kidney disease. The main finding of our analysis was the presence of an 8-fold increase in all-cause mortality in the entire cohort between high and low RDW tertile. Cox hazard analysis identi-fied RDW as an independent predictive factor of mortality in all patients (HR 2.8; 95% CI 2.1-3.8; p < 0.0001) and in subgroups of patients with ischemic (HR 2.8; 95% CI 2.0-3.9; p < 0.0001) and non-ischemic (HR 3.3; 95% CI 2.01-5.5; p < 0.0001) LVSD. CONCLUSIONS The highest RDW tertile was independently associated with higher long-term mortality compared with low and medium tertiles, both in all patients with a LVEF ≤ 35% and in subgroups of patients with ischemic and non-ischemic LVSD.
Kardiologia Polska | 2017
Piotr Buchta; Mateusz Tajstra; Anna Kurek; Michał Skrzypek; Małgorzata Świetlińska; Elżbieta Gadula-Gacek; Michał Wasiak; Łukasz Pyka; Mariusz Gąsior
BACKGROUND The population of patients with implanted cardioverter-defibrillators (ICD) and cardiac resynchronisation therapy devices (CRT-D) is constantly growing. The use of remote-monitoring (RM) techniques in this group can significantly improve clinical outcomes, but there are limited data about the impact of RM on healthcare costs from a payers perspective. AIM The aim of the study was to assess the impact on costs for the healthcare system of RM in patients with ICD or CRT-D. METHODS We examined a cohort of 842 patients with ICD or CRT-D. The group was divided into two groups based on RM (or no RM [NRM]), matched according to important clinical characteristics. The subjects were followed for a maximum of three years after implantation (mean follow-up 2.11 ± 0.83 years). The overall costs for the healthcare provider in the follow-up were defined as the primary endpoint. The secondary endpoint was the use of different types of medical contact events: hospitalisation and number of in-clinic and general practitioner visits (without the number of remote transmissions). RESULTS In the three-year follow-up, the reduction in the costs of treatment for National Health Care in the RM group was 33.5% (median value, p < 0.001). In patients with implanted CRT-D, the reduction reached 42.7% (p = 0.011), and with ICD it was 31.3% (p = 0.007). We observed no significant reduction in the median hospitalisation costs in the three-year follow-up in the RM group (p = NS), despite a 25% drop in the mean value. The costs of outpatient visits were slightly higher in the RM group (p = NS). In the follow-up period, there was no reduction in the number of medical contact events (p = NS). CONCLUSIONS Remote monitoring in patients with implanted ICD or CRT-D devices reduces the cost for the national healthcare provider.
Jacc-cardiovascular Interventions | 2016
Mateusz Tajstra; Łukasz Pyka; Jarosław Gorol; Damian Pres; Marek Gierlotka; Elżbieta Gadula-Gacek; Anna Kurek; Michał Wasiak; Michał Hawranek; Michał Zembala; Andrzej Lekston; Lech Poloński; Leszek Bryniarski; Mariusz Gąsior
Europace | 2018
Anna Kurek; Mateusz Tajstra; Elżbieta Gadula-Gacek; Piotr Buchta; Lukasz Pyka; Michał Wasiak; M Swietlinska; Lech Poloński; Mariusz Gasior
Europace | 2016
Mateusz Tajstra; Elżbieta Gadula-Gacek; Kurek Anna; Adamowicz-Czoch Elżbieta; Olszowski Dawid; Ostręga Mateusz; Łukasz Pyka; Ciślak Aneta; Michał Wasiak; Mariusz Gąsior
Europace | 2016
Piotr Buchta; Mateusz Tajstra; Anna Kurek; Michał Skrzypek; Małorzata ŚWietlińska; Elżbieta Gadula-Gacek; Michał Wasiak; Łukasz Pyka; Mariusz Gąsior
Europace | 2016
Michał Wasiak; Mateusz Tajstra; Kurek Anna; Elżbieta Gadula-Gacek; Adamowicz-Czoch Elżbieta; Olszowski Dawid; Ostręga Mateusz; Łukasz Pyka; Michał Skrzypek; Mariusz Gąsior
Europace | 2016
Anna Kurek; Mateusz Tajstra; Elżbieta Gadula-Gacek; Piotr Buchta; Łukasz Pyka; Michał Wasiak; Małgorzata Świetlińska; Michał Hawranek; Lech Poloński; Mariusz Gąsior